Helix BioPharma(TSE:HBP)
CA$0.86+0.06 (+7.50%)
TSE:HBP
Helix BioPharma financials statements
CA$0.86
At close:+0.06 (+7.50%)
Want to see TSE:HBP full AI Analyst Report?
Helix BioPharma (HBP) Income Statement
32 Followers
Helix BioPharma Income Statement
Last quarter (Q4 2026), Helix BioPharma's total revenue was C$0.00. In Q4, Helix BioPharma's net income was C$-980.00K. See Helix BioPharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jul 26 | Jul 25 | Jul 24 | Jul 23 | Oct 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -4.00K | C$ -10.00K | C$ -14.00K | C$ -13.00K | C$ -12.00K | |
| C$ 3.64M | C$ 5.42M | C$ 9.36M | C$ 6.33M | C$ 6.04M | |
| Depreciation and Amortization | C$ 4.00K | C$ 10.00K | C$ 14.00K | C$ 13.00K | C$ 12.00K |
| C$ -3.65M | C$ -5.21M | C$ -9.38M | C$ -6.31M | C$ -6.03M | |
| C$ -3.64M | C$ -5.42M | C$ -9.37M | C$ -6.28M | C$ -6.54M | |
| C$ 285.00K | C$ 192.00K | C$ -25.00K | C$ 36.00K | C$ -523.00K | |
| C$ -3.35M | C$ -5.23M | C$ -9.40M | C$ -6.29M | C$ -6.56M | |
| C$ -3.35M | C$ -5.21M | C$ -9.26M | C$ -6.29M | C$ -6.08M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.04 | C$ -0.09 | C$ -0.21 | C$ -0.16 | C$ -0.20 |
| Diluted EPS | C$ -0.04 | C$ -0.09 | C$ -0.21 | C$ -0.16 | C$ -0.20 |
| Weighted Average Shares Outstanding | 76.25M | 55.74M | 44.49M | 38.65M | 29.90M |
| Weighted Average Shares Outstanding (Diluted) | 76.25M | 55.74M | 44.49M | 38.65M | 29.90M |
Currency in CAD

